3-(2-benzofuranyl)quinuclidin-2-ene derivatives: Novel muscarinic antagonists

Journal of Medicinal Chemistry

Volumn 39, Issue 17, 1996, Pages 3269-3277

  Nordvall, Gunnar ^a   Sundquist, Staffan ^b   Johansson, Gary ^a   Glas, Gunilla ^b   Nilvebrant, Lisbeth ^b   Hacksell, Uli ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; QUINUCLIDINE DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLADDER; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; MALE; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BLOCKING;

EID: 0029768929     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950455c     Document Type: Article

References (73)

1. See, for example: (a) Davis, R.; Raby, C.; Callahan, M. J.; Lipinski, W.; Schwarz, R.; Dudley, D. T.; Lauffer, D.; Reece, P.; Jaen, J.; Tecle, H. Subtype Selective Muscarinic Agonists - Potential Therapeutic Agents for Alzheimer's Disease. Cholinergic Funct. Dysfunct. 1993, 98, 445. (b) Davidson, M.; Stern, R. G.; Bierer, L. M.; Horvath, T. B.; Zemishlani, Z.; Markofsky, R.; Mohs, R. C. Cholinergic Strategies in the Treatment of Alzheimer's Disease. Acta Psychiatr. Scand. 1991, 83, 47-51.
2. See, for example: (a) Davis, R.; Raby, C.; Callahan, M. J.; Lipinski, W.; Schwarz, R.; Dudley, D. T.; Lauffer, D.; Reece, P.; Jaen, J.; Tecle, H. Subtype Selective Muscarinic Agonists - Potential Therapeutic Agents for Alzheimer's Disease. Cholinergic Funct. Dysfunct. 1993, 98, 445. (b) Davidson, M.; Stern, R. G.; Bierer, L. M.; Horvath, T. B.; Zemishlani, Z.; Markofsky, R.; Mohs, R. C. Cholinergic Strategies in the Treatment of Alzheimer's Disease. Acta Psychiatr. Scand. 1991, 83, 47-51.
3. Eberlein, W. G.; Hasselbach, K. M.; Mayer, N.; Mihm, G.; Rudolf, K.; Doods, H. Trends In Receptor Research; Elsevier Science Publishers B.V.: Amsterdam, 1992; pp 231-249.
4. 2 Antagonists: Novel Structures and Pharmacology. Life Sci. 1993, 52, 497-503.
5. Doods, H. N. Selective Muscarinic Antagonists as Bronchodilators. Drug News Perspect. 1992, 5, 345-352.
6. (a) Wang, P.; Luthin, G. R.; Ruggieri, M. R. Muscarinic Acetylcholine Receptor Subtypes Mediating Urinary Bladder Contractility and Coupling to GTP Binding Proteins. J. Pharmacol, Exp. Ther. 1995, 273, 959-966.
7. (b) Alberts, P. Classification of the Presynaptic Muscarinic Receptor Subtype that 3H-Acetylcholine Secretion in the Guinea Pig Urinary Bladder In Vitro. J. Pharmacol. Exp. Ther. 1995, 274, 458-468.
8. Caulfield, M. P. Muscarinic Receptors - Characterization, Coupling and Function. Pharmacol. Ther. 1993, 55, 319-379.
9. Nilsson, B. M.; Sundquist, S.; Johansson, G.; Nordvall, G.; Glas, G.; Nilvebrant, L.; Hacksell, U. J. Med. Chem. 1995, 38, 473-487.
10. See, for example: (a) Saunders, J.; Cassidy, M.; Freedman, S. B.; Harley, E. A.; Iversen, L. L.; Kneen, C.; Macleod, A. M.; Merchant, K. J.; Snow, R. J.; Baker, R. Novel Quinuclidine-Based Ligands for the Muscarinic Cholinergic Receptor. J. Med. Chem. 1990, 33, 1128-1138. (b) Street, L. J.; Baker, R.; Book, T.; Kneen, C. O.; Macleod, A. M.; Merchant, K. J.; Showell, G. A.; Saunders, J.; Herbert, R. H.; Freedman, S. B.; Harley, E. A. Synthesis and Biological Activity of 1,2,4-Oxadiazole Derivatives: Highly Potent and Efficacious Agonists for Cortical Muscarinic Receptors. J. Med. Chem. 1990, 33, 2690-2697. (c) Wadsworth, H. J.; Jenkins, S. M.; Orlek, B. S.; Cassidy, F.; Clark, M. S. G.; Brown, F.; Riley, G. J.; Graves, D.; Hawkins, J.; Naylor, C. B. Synthesis and Muscarinic Activities of Quinuclidin-3-yltriazole and -tetrazole Derivatives. J. Med. Chem. 1992, 35, 1280-1290.
11. See, for example: (a) Saunders, J.; Cassidy, M.; Freedman, S. B.; Harley, E. A.; Iversen, L. L.; Kneen, C.; Macleod, A. M.; Merchant, K. J.; Snow, R. J.; Baker, R. Novel Quinuclidine-Based Ligands for the Muscarinic Cholinergic Receptor. J. Med. Chem. 1990, 33, 1128-1138. (b) Street, L. J.; Baker, R.; Book, T.; Kneen, C. O.; Macleod, A. M.; Merchant, K. J.; Showell, G. A.; Saunders, J.; Herbert, R. H.; Freedman, S. B.; Harley, E. A. Synthesis and Biological Activity of 1,2,4-Oxadiazole Derivatives: Highly Potent and Efficacious Agonists for Cortical Muscarinic Receptors. J. Med. Chem. 1990, 33, 2690-2697. (c) Wadsworth, H. J.; Jenkins, S. M.; Orlek, B. S.; Cassidy, F.; Clark, M. S. G.; Brown, F.; Riley, G. J.; Graves, D.; Hawkins, J.; Naylor, C. B. Synthesis and Muscarinic Activities of Quinuclidin-3-yltriazole and -tetrazole Derivatives. J. Med. Chem. 1992, 35, 1280-1290.
12. See, for example: (a) Saunders, J.; Cassidy, M.; Freedman, S. B.; Harley, E. A.; Iversen, L. L.; Kneen, C.; Macleod, A. M.; Merchant, K. J.; Snow, R. J.; Baker, R. Novel Quinuclidine-Based Ligands for the Muscarinic Cholinergic Receptor. J. Med. Chem. 1990, 33, 1128-1138. (b) Street, L. J.; Baker, R.; Book, T.; Kneen, C. O.; Macleod, A. M.; Merchant, K. J.; Showell, G. A.; Saunders, J.; Herbert, R. H.; Freedman, S. B.; Harley, E. A. Synthesis and Biological Activity of 1,2,4-Oxadiazole Derivatives: Highly Potent and Efficacious Agonists for Cortical Muscarinic Receptors. J. Med. Chem. 1990, 33, 2690-2697. (c) Wadsworth, H. J.; Jenkins, S. M.; Orlek, B. S.; Cassidy, F.; Clark, M. S. G.; Brown, F.; Riley, G. J.; Graves, D.; Hawkins, J.; Naylor, C. B. Synthesis and Muscarinic Activities of Quinuclidin-3-yltriazole and -tetrazole Derivatives. J. Med. Chem. 1992, 35, 1280-1290.
13. (a) Castro, C. E.; Stephens, R. D. Substitutions by Ligands of Low Valent Transition Metals. A Preparation of Tolanes and Heterocyclics from Aryl Iodides and Cuprous Acetylides. J. Org. Chem. 1963, 28, 2163.
14. (b) Stephens, R. D.; Castro, C. E. The Substitution of Aryl Iodides with Cuprous Acetylides. A Synthesis of Tolanes and Heterocyclics. J. Org. Chem. 1963, 28, 3313-3315.
15. (c) Castro, C. E.; Gaughan, E. J.; Owsley, D. C. Indoles, Benzofurans, Phtalides, and Tolanes via Copper(I) Acetylides. J. Org. Chem. 1966, 31, 4071-4078.
16. (d) Castro, C. B.; Havlin, R.; Honwad, V. K.; Malte, A.; Mojé, S. Copper(I) Substitutions. Scope and Mechanism of Cuprous Acetylide Substitutions. J. Am. Chem. Soc. 1969, 91, 6464-6470. For reviews describing the Stephens-Castro reaction, see also: Posner, G. H. Substitution Reactions Using Organocopper Reagents. Org. React. 1975, 22, 253-400. Haglund, O. Copper-Mediated Vicarious Nucleophilic Substitution. Thesis, University of Gothenburg, 1993.
17. (d) Castro, C. B.; Havlin, R.; Honwad, V. K.; Malte, A.; Mojé, S. Copper(I) Substitutions. Scope and Mechanism of Cuprous Acetylide Substitutions. J. Am. Chem. Soc. 1969, 91, 6464-6470. For reviews describing the Stephens-Castro reaction, see also: Posner, G. H. Substitution Reactions Using Organocopper Reagents. Org. React. 1975, 22, 253-400. Haglund, O. Copper-Mediated Vicarious Nucleophilic Substitution. Thesis, University of Gothenburg, 1993.
18. (d) Castro, C. B.; Havlin, R.; Honwad, V. K.; Malte, A.; Mojé, S. Copper(I) Substitutions. Scope and Mechanism of Cuprous Acetylide Substitutions. J. Am. Chem. Soc. 1969, 91, 6464-6470. For reviews describing the Stephens-Castro reaction, see also: Posner, G. H. Substitution Reactions Using Organocopper Reagents. Org. React. 1975, 22, 253-400. Haglund, O. Copper-Mediated Vicarious Nucleophilic Substitution. Thesis, University of Gothenburg, 1993.
19. 1 Receptors. Tetrahedron 1992, 48, 10339-10344. (e) Yang, Z.; Liu, H. B.; Lee, C. M.; Chang, H. M.; Wong, H. N. C. Regioselective Introduction of Carbon-3 Substituents to 5-Alkyl-7-methoxy-2-phenylbenzo[b]furans - Synthesis of a Novel Adenosine-A1 Receptor Ligand and Its Derivatives. J. Org. Chem. 1992, 57, 7248-7257. (f) Zubia, E.; Luis, F. R.; Massanet, G. M.; Collado, I. G. An Efficient Synthesis of Furanocoumarins. Tetrahedron 1992, 48, 4239-4246.
20. 1 Receptors. Tetrahedron 1992, 48, 10339-10344. (e) Yang, Z.; Liu, H. B.; Lee, C. M.; Chang, H. M.; Wong, H. N. C. Regioselective Introduction of Carbon-3 Substituents to 5-Alkyl-7-methoxy-2-phenylbenzo[b]furans - Synthesis of a Novel Adenosine-A1 Receptor Ligand and Its Derivatives. J. Org. Chem. 1992, 57, 7248-7257. (f) Zubia, E.; Luis, F. R.; Massanet, G. M.; Collado, I. G. An Efficient Synthesis of Furanocoumarins. Tetrahedron 1992, 48, 4239-4246.
21. 1 Receptors. Tetrahedron 1992, 48, 10339-10344. (e) Yang, Z.; Liu, H. B.; Lee, C. M.; Chang, H. M.; Wong, H. N. C. Regioselective Introduction of Carbon-3 Substituents to 5-Alkyl-7-methoxy-2-phenylbenzo[b]furans - Synthesis of a Novel Adenosine-A1 Receptor Ligand and Its Derivatives. J. Org. Chem. 1992, 57, 7248-7257. (f) Zubia, E.; Luis, F. R.; Massanet, G. M.; Collado, I. G. An Efficient Synthesis of Furanocoumarins. Tetrahedron 1992, 48, 4239-4246.
22. 1 Receptors. Tetrahedron 1992, 48, 10339-10344. (e) Yang, Z.; Liu, H. B.; Lee, C. M.; Chang, H. M.; Wong, H. N. C. Regioselective Introduction of Carbon-3 Substituents to 5-Alkyl-7-methoxy-2-phenylbenzo[b]furans - Synthesis of a Novel Adenosine-A1 Receptor Ligand and Its Derivatives. J. Org. Chem. 1992, 57, 7248-7257. (f) Zubia, E.; Luis, F. R.; Massanet, G. M.; Collado, I. G. An Efficient Synthesis of Furanocoumarins. Tetrahedron 1992, 48, 4239-4246.
23. 1 Receptors. Tetrahedron 1992, 48, 10339-10344. (e) Yang, Z.; Liu, H. B.; Lee, C. M.; Chang, H. M.; Wong, H. N. C. Regioselective Introduction of Carbon-3 Substituents to 5-Alkyl-7-methoxy-2-phenylbenzo[b]furans - Synthesis of a Novel Adenosine-A1 Receptor Ligand and Its Derivatives. J. Org. Chem. 1992, 57, 7248-7257. (f) Zubia, E.; Luis, F. R.; Massanet, G. M.; Collado, I. G. An Efficient Synthesis of Furanocoumarins. Tetrahedron 1992, 48, 4239-4246.
24. 1 Receptors. Tetrahedron 1992, 48, 10339-10344. (e) Yang, Z.; Liu, H. B.; Lee, C. M.; Chang, H. M.; Wong, H. N. C. Regioselective Introduction of Carbon-3 Substituents to 5-Alkyl-7-methoxy-2-phenylbenzo[b]furans - Synthesis of a Novel Adenosine-A1 Receptor Ligand and Its Derivatives. J. Org. Chem. 1992, 57, 7248-7257. (f) Zubia, E.; Luis, F. R.; Massanet, G. M.; Collado, I. G. An Efficient Synthesis of Furanocoumarins. Tetrahedron 1992, 48, 4239-4246.
25. Several groups have used palladium catalysis to perform similar types of reactions; see, for example: (a) Villemin, D.; Goussu, D. Palladium Homogeneous and Supported Catalysis: Synthesis of Functional Acetylenics and Cyclisation to heterocycles. Heterocycles 1989, 29, 1255-1261. (b) Candiani, I.; DeBernadinis, S.; Cabri, W.; Marchi, M.; Bedeschi, A.; Penco, S. A Facile One-Pot Synthesis of Polyfunctionalized 2-Unsubstituted Benzo[b]-furans. Syn. Lett. 1993, 269-270.
26. Several groups have used palladium catalysis to perform similar types of reactions; see, for example: (a) Villemin, D.; Goussu, D. Palladium Homogeneous and Supported Catalysis: Synthesis of Functional Acetylenics and Cyclisation to heterocycles. Heterocycles 1989, 29, 1255-1261. (b) Candiani, I.; DeBernadinis, S.; Cabri, W.; Marchi, M.; Bedeschi, A.; Penco, S. A Facile One-Pot Synthesis of Polyfunctionalized 2-Unsubstituted Benzo[b]-furans. Syn. Lett. 1993, 269-270.
27. (a) Clemo, G. R.; Hoggarth, E. 81. 5-Ethinylruban-5-ol and Related Compounds. J. Chem. Soc. 1941, 476-477.
28. (b) Ernest, J. Collect. Czech. Chem. Commun. 1950, 15, 322-334.
29. Doad, G. J. S.; Barltrop, J. A.; Petty, C. M.; Owen, T. C. A Versatile and Convenient Synthesis of Benzofurans. Tetrahedron Lett. 1989, 30, 1597-1598.
30. Attempts to synthesize quinuclidin-2-ene derivatives directly from 3-ethynylquinuclidin-2-ene and an ortho-halogenated phenol were unsuccessful.
31. For the preparation of 2-phenylfuro[3,2-b]pyridine using the Steven-Castro reaction, see: Owsley, D. C.; Castro, C. E. Substitution of Aryl Halides with Copper(I) Acetylides: 2-phenylfuro[3,2-b]pyridine. Org. Synth. 1972, 52, 128-131.
32. Eggler, J. F.; Holland, G. F.; Johnson, M. R.; Volkmann, R. A. International Patent No. WO 86/07056, 1986; Chem. Abstr. 1987, 107:39794q.
33. Helquist, P. Palladium Hydrides in Organic Synthesis. Reduction of Aryl Bromides by Sodium Formate Catalyzed by Tetrakis-(triphenylphosphine)palladium. Tetrahedron Lett. 1978, 1913-1914.
34. Davies, S. G.; Pyatt, D. Synthesis of 1-Substituted Derivatives of Codeine from 1-Bromocodeine via Palladium Catalysed Coupling Reactions. Heterocycles 1989, 28, 163-166.
35. Peters, D.; Hörnfeldt, A.-B.; Gronowitz, S.; Johansson N.-G. Synthesis of various 5-substituted 2′-deoxy-3′,5′-di-O-acetyluridines. J. Heterocycl. Chem. 1991, 28, 529-531.
36. See, for example: Kursanov, D. N.; Parnes, Z. N.; Loim, N. M. Applications of Ionic Hydrogenation to Organic Synthesis. Synthesis 1974, 633-651 and references cited therein.
37. The corresponding reaction with 25 produced a mixture of products with 28 present only in small amounts according to TLC.
38. The quinuclidin-3-ol derivatives were not tested since they were expected to show significantly lower affinity than the corresponding quinuclidin-2-ene congeners; compare ref 7.
39. Nilvebrant, L.; Sparf, B. Muscarinic Receptor Binding in the Parotid Gland. Different Affinities of Some Ariticholinergic Drugs between the Parotid Gland and Ileum. Scand. J. Gastroenterol. 1982, 17 (Suppl. 72), 69-77.
40. Nilvebrant, L.; Sparf, B. Muscarinic Receptor Binding in the Guinea Pig Urinary Bladder. Acta Pharmacol. Toxicol. 1983, 52, 30-38.
41. Nilvebrant, L.; Sparf, B. Dicyclomine, Benzhexol and Oxybutynin Distinguish Between Sub-Classes of Muscarinic Binding-sites. Eur. J. Pharmacol. 1986, 123, 133-143.
42. Nilvebrant, L.; Sparf, B. Differences Between Binding Affinities of Some Antimuscarinic Drugs in the Parotid Gland and those in the Urinary Bladder and Ileum. Acta Pharmacol. Toxicol. 1983, 53, 304-313.
43. (a) Nilvebrant, L.; Sparf, B. Differences Between Binding Affinities of Some Antimuscarinic Drugs in the Parotid Gland and those in the Urinary Bladder and Ileum. Acta Pharmacol. Toxicol. 1983, 53, 304-313.
44. (b) Nilvebrant, L.; Sparf, B. Dicyclomine, Benzhexol and Oxybutynin Distinguish Between Sub-Classes of Muscarinic Binding-sites. Eur. J. Pharmacol. 1986, 123, 133-143.
45. (a) Cramer, R. D., III; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
46. (b) Cramer, R. D., III; Depriest, S. A.; Patterson, D. E.; Hecht, P. The Developing Practice of Comparative Molecular Field Analysis. In 3D QSAR in Drug Design: Theory, Methods and Applications; Kubinyi, H., Ed.; ESCOM: Leiden, 1993; pp 443-485.
47. (c) Van Steen, B. J.; Van Wijngaarden, I.; Tulp, M. T.; Soudijn, W. Structure-affinity relationship studies on 5-HT1A receptor ligands. 2. Heterobicyclic phenylpiperazines with N4-aralkyl substituents. J. Med. Chem. 1994, 37, 2761-2773.
48. For a recent compilation of π and MR values, see: Hansch, C.; Leo, A.; Hoekman, D. Exploring QSAR. Hydrophobic, Electronic, and Steric Constants; American Chemical Society: Washington, DC, 1995.
49. Verloop A. The STERIMOL Approach to Drug Design; Decker: New York, 1987.
50. Wavefuncion, Inc., 18401 Von Karman Ave., #370, Irvine, CA 92715.
51. The SPARTAN-calculated hardness is one-half of the difference between the HOMO and LUMO energies.
52. The ovality is calculated by SPARTAN in the following way: ovality = surface area/4π(3*mol vol/4π)**2/3, where π = 3.141 5926.
53. Wold, S.; Albano, C.; Dunn, W. J., III; Edlund, U.; Esbensen, K.; Geladi, P.; Hellberg, S.; Johansson, E.; Lindberg, W.; Sjöström, M. In Chemometrics - Mathematics and Statistics in Chemistry; Kowalski, B. R., Ed.; Reidel: Dordrecht, 1984; pp 17-95.
54. SIMCA-S computes the influence on Y of every X in the model, called VIP (variable importance in the projection). The variables with the highest VIP score have the highest influence on the model.
55. See, for example, ref 8a.
56. This indicates the π value for the substituent in the 5-position of the benzofuran ring. Similarly, a suffix of -7 indicates the 7-position.
57. 2 - 0.13*π-5*L-7.
58. 1,(cortex) = 9.76 + 0.54433*π-5 - 0.13082*MR-5 + 0.26787*σ(meta)-5 + 0.11137*σ(para)-5 - 0.16527*L-5 - 0.13734*B1-5 - 0.62835*B5-5.
59. Bastiansen, O.; Samdal, S. Structure and Barrier of internal Rotation of Biphenyl Derivatives in the Gaseous State. J. Mol. Struct. 1985, 128, 115-125.
60. 2 as noted previously; see, e.g., ref 28b.
61. Wolfe, B. B.; Yasuda, R. P. Development of Selective Antisera for Muscarinic Cholinergic Receptor Subtypes. Ann. N. Y. Acad. Sci. 1995, 151, 186-193.
62. Levey, A. I.; Kitt, C. H.; Simonds, W. F.; Price, D. L.; Brann, M. R. Identification and Localisation of Muscarinic Acetylcholine Receptor Proteins with Subtype-specific Antibodies. J. Neurosci. 1991, 11, 3218-3226.
63. Peralta, E. G.; Ashkenazi, A.; Winslow, J. W.; Smith, D. H.; Ramachandran, J.; Capon, D. J. Distinct Primary Structure, Ligand-Binding Properties and Tissue-Specific Expression of Four Human Muscarinic Acetylcholine Receptors. EMBO J. 1987, 6, 3923-3929.
64. Dorje, F.; Levey, A. I.; Brann, M. R. Immunological Detection of Muscarinic Receptor Subtype Proteins (m1-M5) in Rabbit Peripheral Tissues. Mol. Pharmacol. 1991, 40, 459-462.
65. Dai, Y.; Ambudkar, I. S.; Horn, V. J.; Yeh, C.-K.; Kousvelari, E. E.; Wall, S. E.; Li, M.; Yasuda, R. P.; Wolfe, B. B.; Baum, B. J. Evidence that M3 Muscarinic Receptors in Rat Parotid Gland Couple to Two Second Messenger Systems. Am. J. Physiol. 1991, 261, c1063-c1073.
66. Wang, P.; Luthin, G. R.; Ruggieri, M. R. Muscarinic Acetylcholine Receptor Subtypes Mediating Urinary Bladder Contractility and Coupling to GTP Binding Proteins. J. Pharmacol. Exp. Ther. 1995, 273, 959-966.
67. Lowry, O. H.; Rosebrough, N. J.; Far, A. L.; Randall, R. J. Protein Mesurements with the Folin Phenol Reagent. J. Biol. Chem. 1951, 193, 265-275.
68. Jacobs, S.; Chang, K.-J.; Cuatrecasas, P. Estimation of Hormone Receptor Affinity by Competitive Displacement of Labelled Ligand. Effects of Concentration of Receptor and Labelled Ligand. Biochem. Biophys. Res. Commun. 1975, 66, 687-692.
69. Schild, H. I. pAx and Competitive Drug Antagonism. Br. J. Pharmacol. Chemother. 1949, 4, 277-280.
70. Umetri AB, Box 1456, S-901 24 Umeá, Sweden.
71. 13C NMR Spectra of 2- or 3-Substituted Furo[2,3-b]-, Furo[3,2-b]-, Furo-[2,3-c]- and Furo[3,2-c]pyndine. J. Heterocycl. Chem. 1991, 28, 1469-1480.
72. 13C NMR Spectra of 2- or 3-Substituted Furo[2,3-b]-, Furo[3,2-b]-, Furo-[2,3-c]- and Furo[3,2-c]pyndine. J. Heterocycl. Chem. 1991, 28, 1469-1480.
73. (b) Hesse, M.; Meier, H.; Zeeh, B. Spectroskopische Methoden in der Organischen Chemie, 2nd ed.; Georg Thieme Verlag: Stuttgart, 1984.